Editorial: The tumor microenvironment and immunotherapy for head and neck tumors.

作者信息

Jiang Yifan, Yang Wenyi, Hu Jingzhou, Tao Lei

机构信息

Department of Otolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.

Department of Oral Maxillofacial & Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Front Oncol. 2025 Jun 4;15:1606787. doi: 10.3389/fonc.2025.1606787. eCollection 2025.

DOI:10.3389/fonc.2025.1606787

PMID:40535144

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12173864/

Abstract

摘要

相似文献

[1]

Editorial: The tumor microenvironment and immunotherapy for head and neck tumors.

Front Oncol. 2025-6-4

[2]

An immune activator encapsulating PD-L1 siRNA for augmented immune checkpoint blockade immunotherapy through Zn overload triggered pyroptosis.

J Nanobiotechnology. 2025-6-16

[3]

Immune checkpoint inhibitor use in head and neck squamous cell carcinoma: the current landscape and future perspectives.

Future Oncol. 2024

[4]

Unraveling the immune evasion mechanisms in the tumor microenvironment of head and neck squamous cell carcinoma.

Front Immunol. 2025-5-14

[5]

Reprogramming Tumor-Associated Macrophage by Ornithine Decarboxylase Inhibitor and Immune Checkpoint for Orthotopic Glioblastoma Photothermal Immunotherapy.

ACS Appl Mater Interfaces. 2025-6-18

[6]

Gut Microbiota Reshapes the Tumor Microenvironment and Affects the Efficacy of Colorectal Cancer Immunotherapy.

Cancer Med. 2025-6

[7]

Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy.

Front Immunol. 2023

[8]

Identification of a gene score related to antigen processing and presentation machinery for predicting prognosis in head and neck squamous cell carcinoma and its potential implications for immunotherapy.

Clin Transl Oncol. 2024-12-31

[9]

The regulatory role of CDK4/6 inhibitors in tumor immunity and the potential value of tumor immunotherapy (Review).

Int J Mol Med. 2025-8

[10]

PMN-MDSCs are responsible for immune suppression in anti-PD-1 treated TAP1 defective melanoma.

Clin Transl Oncol. 2025-1-18

本文引用的文献

[1]

Single-Cell Analyses Reveal the Metabolic Heterogeneity and Plasticity of the Tumor Microenvironment during Head and Neck Squamous Cell Carcinoma Progression.

Cancer Res. 2024-8-1

[2]

The Tumor Immune Microenvironment Architecture Correlates with Risk of Recurrence in Head and Neck Squamous Cell Carcinoma.

Cancer Res. 2023-12-1

[3]

Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response.

Nat Commun. 2023-8-18

[4]

Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8 T cells.

Mol Oncol. 2023-8

[5]

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment.

Nat Rev Cancer. 2023-3

[6]

Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.

Drug Resist Updat. 2022-1

[7]

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer.

Immunity. 2020-1-7

[8]

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.

Lancet. 2019-11-1

[9]

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

N Engl J Med. 2016-11-10

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Editorial: The tumor microenvironment and immunotherapy for head and neck tumors.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

本文引用的文献